🚀 VC round data is live in beta, check it out!
Mach7 Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mach7 Technologies and similar public comparables like HeartBeam, PharmX Technologies, MeVis, BIT Computer and more.
Mach7 Technologies Overview
About Mach7 Technologies
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company’s vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
Founded
1977
HQ
Employees
103
Website
Financials (LTM)
EV
$41M
Mach7 Technologies Financials
Mach7 Technologies reported last 12-month revenue of $22M and negative EBITDA of ($384K).
In the same LTM period, Mach7 Technologies generated ($384K) in EBITDA losses and had net loss of ($4M).
Revenue (LTM)
Mach7 Technologies P&L
In the most recent fiscal year, Mach7 Technologies reported revenue of $16M and EBITDA of ($1M).
Mach7 Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $22M | XXX | $16M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 80% | XXX | XXX | XXX |
| EBITDA | ($384K) | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (7%) | XXX | XXX | XXX |
| EBIT Margin | (24%) | XXX | (35%) | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (20%) | XXX | (25%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mach7 Technologies Stock Performance
Mach7 Technologies has current market cap of $54M, and enterprise value of $41M.
Market Cap Evolution
Mach7 Technologies' stock price is $0.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $41M | $54M | 0.2% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMach7 Technologies Valuation Multiples
Mach7 Technologies trades at 1.9x EV/Revenue multiple, and (107.3x) EV/EBITDA.
EV / Revenue (LTM)
Mach7 Technologies Financial Valuation Multiples
As of March 17, 2026, Mach7 Technologies has market cap of $54M and EV of $41M.
Equity research analysts estimate Mach7 Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mach7 Technologies has a P/E ratio of (12.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $54M | XXX | $54M | XXX | XXX | XXX |
| EV (current) | $41M | XXX | $41M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | (107.3x) | XXX | (35.5x) | XXX | XXX | XXX |
| EV/EBIT | (8.0x) | XXX | (7.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.1x | XXX | XXX | XXX |
| P/E | (12.4x) | XXX | (13.3x) | XXX | XXX | XXX |
| EV/FCF | (65.7x) | XXX | (159.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mach7 Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mach7 Technologies Margins & Growth Rates
Mach7 Technologies' revenue in the last 12 month grew by 21%.
Mach7 Technologies' revenue per employee in the last FY averaged $0.2M.
Mach7 Technologies' rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mach7 Technologies' rule of X is 51% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mach7 Technologies Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | 44% | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Growth | (487%) | XXX | (94%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 124% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 172% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mach7 Technologies Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| HeartBeam | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmX Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| MeVis | XXX | XXX | XXX | XXX | XXX | XXX |
| BIT Computer | XXX | XXX | XXX | XXX | XXX | XXX |
| Deepnoid | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mach7 Technologies M&A Activity
Mach7 Technologies acquired XXX companies to date.
Last acquisition by Mach7 Technologies was on XXXXXXXX, XXXXX. Mach7 Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mach7 Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMach7 Technologies Investment Activity
Mach7 Technologies invested in XXX companies to date.
Mach7 Technologies made its latest investment on XXXXXXXX, XXXXX. Mach7 Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mach7 Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mach7 Technologies
| When was Mach7 Technologies founded? | Mach7 Technologies was founded in 1977. |
| Where is Mach7 Technologies headquartered? | Mach7 Technologies is headquartered in United States. |
| How many employees does Mach7 Technologies have? | As of today, Mach7 Technologies has over 103 employees. |
| Is Mach7 Technologies publicly listed? | Yes, Mach7 Technologies is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Mach7 Technologies? | Mach7 Technologies trades under M7T ticker. |
| When did Mach7 Technologies go public? | Mach7 Technologies went public in 2005. |
| Who are competitors of Mach7 Technologies? | Mach7 Technologies main competitors are HeartBeam, PharmX Technologies, MeVis, BIT Computer. |
| What is the current market cap of Mach7 Technologies? | Mach7 Technologies' current market cap is $54M. |
| What is the current revenue of Mach7 Technologies? | Mach7 Technologies' last 12 months revenue is $22M. |
| What is the current revenue growth of Mach7 Technologies? | Mach7 Technologies revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Mach7 Technologies? | Current revenue multiple of Mach7 Technologies is 1.9x. |
| Is Mach7 Technologies profitable? | No, Mach7 Technologies is not profitable. |
| What is the current EBITDA of Mach7 Technologies? | Mach7 Technologies has negative EBITDA and is not profitable. |
| What is Mach7 Technologies' EBITDA margin? | Mach7 Technologies' last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of Mach7 Technologies? | Current EBITDA multiple of Mach7 Technologies is (107.3x). |
| What is the current FCF of Mach7 Technologies? | Mach7 Technologies' last 12 months FCF is ($627K). |
| What is Mach7 Technologies' FCF margin? | Mach7 Technologies' last 12 months FCF margin is (3%). |
| What is the current EV/FCF multiple of Mach7 Technologies? | Current FCF multiple of Mach7 Technologies is (65.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.